Table 2.
Biomarkers levels and risk of disease status.
| Disease status | Biomarkers level | OR (95% confidence interval) |
P-value |
|---|---|---|---|
| Obesity | Vanin-1 > 1.574 ng/ml |
0.637 (0.17–2.28) |
0.489 |
|
Pantothenic acid < 850.27 ng/ml |
2.853 (0.51–15.99) |
0.233 | |
|
Diabetes in patients without obesity |
Vanin-1 > 1.574 ng/ml |
0.664 (0.11–3.81) |
0.642 |
|
Pantothenic acid < 850.27 ng/ml |
5.124 (0.73–35.73) |
0.099 | |
|
Diabetes in patients with obesity |
Vanin-1 > 1.574 ng/ml |
2.146 (0.59–7.57) |
0.235 |
|
Pantothenic acid < 850.27 ng/ml |
7.610 (1.37–42.05) |
0.02 | |
|
Diabetes with CVD in patients without obesity |
Vanin-1 > 1.574 ng/ml |
1.616 (0.363–7.19) |
0.529 |
|
Pantothenic acid < 850.27 ng/ml |
7.237 (1.11–47.10) |
0.038 | |
|
Diabetes with CVD in patients with obesity |
Vanin-1 > 1.574 ng/ml |
1.326 (0.349–5.03) |
0.679 |
|
Pantothenic acid < 850.27 ng/ml |
12.028 (2.23–64.76) |
0.004 |
Significant values are in [bold].
CVD, cardiovascular disease; OR, odds ratio.